» Articles » PMID: 37638324

Current Insights in the Molecular Genetic Pathogenesis of Amyotrophic Lateral Sclerosis

Overview
Journal Front Neurosci
Date 2023 Aug 28
PMID 37638324
Authors
Affiliations
Soon will be listed here.
Abstract

Amyotrophic lateral sclerosis (ALS) is a progressive and fatal neurodegenerative disease that leads to the massive loss of motor neurons in cerebrum, brain stem and spinal cord. It affects not only motor neurons but also other neurons and glial cells, resulting in the progressive muscle atrophy, the severe disability and the eventual death due to the respiratory failure. The pathogenesis of ALS is not fully understood. Currently, several factors are considered to be involved in the pathogenesis of ALS, such as genetic factors, imbalances in protein homeostasis, RNA metabolism disorders, mitochondrial dysfunctions, glutamate-mediated excitatory toxicities and intra-neuronal material transport disorders in neurons. The study of genetic mutations related to ALS pathogenesis will link the molecular and cellular mechanisms of the disease, thus enhancing the understanding of its occurrence and progression, thereby providing new insights for the pathogenesis of ALS. This review summarizes the current insights in the molecular genetic pathogenesis of ALS.

Citing Articles

Mitochondrial respiratory complex IV deficiency recapitulates amyotrophic lateral sclerosis.

Cheng M, Lu D, Li K, Wang Y, Tong X, Qi X Nat Neurosci. 2025; .

PMID: 40069360 DOI: 10.1038/s41593-025-01896-4.


Clinical features and progress in diagnosis and treatment of amyotrophic lateral sclerosis.

Yuan D, Jiang S, Xu R Ann Med. 2024; 56(1):2399962.

PMID: 39624969 PMC: 11616751. DOI: 10.1080/07853890.2024.2399962.


Genetic Modifiers of ALS: The Impact of Chromogranin B P413L in a Bulgarian ALS Cohort.

Tourtourikov I, Todorov T, Angelov T, Chamova T, Tournev I, Mitev V Genes (Basel). 2024; 15(9).

PMID: 39336788 PMC: 11431727. DOI: 10.3390/genes15091197.


Decreased spinal cord motor neuron numbers in mice depleted of central nervous system copper.

Liddell J, Hilton J, Wang Y, Billings J, Nikseresht S, Kysenius K Metallomics. 2024; 16(9).

PMID: 39251386 PMC: 11879390. DOI: 10.1093/mtomcs/mfae036.


Astrocyte-Neuron Interactions Contributing to Amyotrophic Lateral Sclerosis Progression.

Jensen B Adv Neurobiol. 2024; 39:285-318.

PMID: 39190080 DOI: 10.1007/978-3-031-64839-7_12.


References
1.
Shoshan-Barmatz V, Shteinfer-Kuzmine A, Verma A . VDAC1 at the Intersection of Cell Metabolism, Apoptosis, and Diseases. Biomolecules. 2020; 10(11). PMC: 7693975. DOI: 10.3390/biom10111485. View

2.
Yamashita T, Kwak S . Cell death cascade and molecular therapy in ADAR2-deficient motor neurons of ALS. Neurosci Res. 2018; 144:4-13. DOI: 10.1016/j.neures.2018.06.004. View

3.
Wani A, Weihl C . Loss-of-function mutation in VCP mimics the characteristic pathology as in FTLD-TARDBP. Autophagy. 2021; 17(12):4502-4503. PMC: 8726662. DOI: 10.1080/15548627.2021.1985880. View

4.
Nassif M, Woehlbier U, Manque P . The Enigmatic Role of C9ORF72 in Autophagy. Front Neurosci. 2017; 11:442. PMC: 5541066. DOI: 10.3389/fnins.2017.00442. View

5.
Sekiyama N, Takaba K, Maki-Yonekura S, Akagi K, Ohtani Y, Imamura K . ALS mutations in the TIA-1 prion-like domain trigger highly condensed pathogenic structures. Proc Natl Acad Sci U S A. 2022; 119(38):e2122523119. PMC: 9499527. DOI: 10.1073/pnas.2122523119. View